Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Avid Bioservices, Inc. (CDMO)

14.99   0.28 (1.9%) 11-28 16:00
Open: 14.48 Pre. Close: 14.71
High: 15.44 Low: 14.48
Volume: 674,147 Market Cap: 932(M)

Technical analysis

as of: 2022-11-28 4:38:36 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 18.63     One year: 20.81
Support: Support1: 12.93    Support2: 10.76
Resistance: Resistance1: 15.95    Resistance2: 17.81
Pivot: 14.45
Moving Average: MA(5): 14.65     MA(20): 14.68
MA(100): 17.4     MA(250): 18.23
MACD: MACD(12,26): -0.5     Signal(9): -0.7
Stochastic oscillator: %K(14,3): 57.3     %D(3): 52.5
RSI: RSI(14): 48.1
52-week: High: 31.01  Low: 11.3
Average Vol(K): 3-Month: 654 (K)  10-Days: 411 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ CDMO ] has closed below upper band by 31.0%. Bollinger Bands are 21.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 15.46 - 15.52 15.52 - 15.56
Low: 14.33 - 14.4 14.4 - 14.46
Close: 14.88 - 14.99 14.99 - 15.08

Company Description

Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. It also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. The company serves biotechnology and biopharmaceutical industries. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc. in January 2018. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California.

Headline News

Tue, 29 Nov 2022
Paras Biopharmaceuticals is Highly Recommended for Biologics CDMO – Development, Scale-up & Production - EIN News

Mon, 28 Nov 2022
Yposkesi is on a roll: CDMO's expanded facility to be operational in early 2024 -

Mon, 28 Nov 2022
Medeologix Acquires Three Silicon Valley Medical Device CDMO Companies and Establishes One-Stop Shop Mass Production Facilities in Taiwan - PR Newswire

Mon, 28 Nov 2022
Vistria teams with GHO to capitalize on pharma CDMO expansion - PE Hub

Mon, 21 Nov 2022
After Chinese CDMO fails, Cambrex acquires ingredient manufacturer Snapdragon Chemistry - Endpoints News

Thu, 17 Nov 2022
Radioisotope company moves forward with CDMO plans, breaking ground on new manufacturing site in Wisconsin - Endpoints News

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 62 (M)
Shares Float 62 (M)
% Held by Insiders 1.4 (%)
% Held by Institutions 109 (%)
Shares Short 4,860 (K)
Shares Short P.Month 5,410 (K)

Stock Financials

EPS 1.77
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 2.88
Profit Margin (%) 97.9
Operating Margin (%) 8.9
Return on Assets (ttm) 1.9
Return on Equity (ttm) 109.9
Qtrly Rev. Growth 19.2
Gross Profit (p.s.) 0.58
Sales Per Share 2.01
EBITDA (p.s.) 0.26
Qtrly Earnings Growth -80
Operating Cash Flow 11 (M)
Levered Free Cash Flow -36 (M)

Stock Valuations

PE Ratio 8.42
PEG Ratio 13.4
Price to Book value 5.2
Price to Sales 7.42
Price to Cash Flow 81.96

Stock Dividends

Dividend 0.66
Forward Dividend 0
Dividend Yield 4.4%
Dividend Pay Date 2017-07-09
Ex-Dividend Date Invalid DateTime.
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.